(Q38599876)

4 September 2017

title

Co-targeting cancer drug escape pathways confers clinical advantage for multi-target anticancer drugs (English)

1 reference

4 September 2017

2

0 references

Yu Zong Chen

6

object named as

Yu Zong Chen

1 reference

4 September 2017

Lin Tao

1

1 reference

4 September 2017

Feng Xu

3

1 reference

4 September 2017

Zhe Chen

4

1 reference

4 September 2017

Yu Yang Jiang

5

1 reference

4 September 2017

publication date

3 October 2015

1 reference

4 September 2017

published in

Pharmacological Research

1 reference

4 September 2017

volume

102

1 reference

4 September 2017

page(s)

123-131

1 reference

Inferring multi-target QSAR models with taxonomy-based multi-task learning.

4 September 2017

cites work

1 reference

https://opencitations.net/index/coci/api/v1/citations/10.1186/1758-2946-5-33

COCI

reference URL

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

2 January 2022

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1141478

EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1038/NM.2577

Identifiers

DOI

10.1016/J.PHRS.2015.09.019

1 reference

4 September 2017

1 reference